Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Current and future directions in Belgian medical and health sciences librarianship: a user-tailored approach.

De Meulemeester A, Schietse B, Vermeeren B, Ghesquière E, Declève G, Buysse H, Discart I, Alewaeters K, Durieux N, Peleman R, Pauwels N.

Health Info Libr J. 2018 Dec;35(4):336-340. doi: 10.1111/hir.12237. Epub 2018 Nov 2.

PMID:
30387540
2.

Communication satisfaction and job satisfaction among critical care nurses and their impact on burnout and intention to leave: A questionnaire study.

Vermeir P, Blot S, Degroote S, Vandijck D, Mariman A, Vanacker T, Peleman R, Verhaeghe R, Vogelaers D.

Intensive Crit Care Nurs. 2018 Oct;48:21-27. doi: 10.1016/j.iccn.2018.07.001. Epub 2018 Jul 20.

PMID:
30033213
3.

Patient perspectives on electronic health record accessibility and patient participation: a questionnaire survey.

Vermeir P, Degroote S, Van Tiggelen H, Vandijck D, Peleman R, Verhaeghe R, Mariman A, Vermeersch H, Vogelaers D.

Acta Clin Belg. 2018 Aug;73(4):292-297. doi: 10.1080/17843286.2018.1436233. Epub 2018 Feb 12.

PMID:
29431035
4.

The patient perspective on the effects of medical record accessibility: a systematic review.

Vermeir P, Degroote S, Vandijck D, Van Tiggelen H, Peleman R, Verhaeghe R, Mariman A, Vogelaers D.

Acta Clin Belg. 2017 Jun;72(3):186-194. doi: 10.1080/17843286.2016.1275375. Epub 2017 Jan 6. Review.

PMID:
28056665
5.

Communication in healthcare: a narrative review of the literature and practical recommendations.

Vermeir P, Vandijck D, Degroote S, Peleman R, Verhaeghe R, Mortier E, Hallaert G, Van Daele S, Buylaert W, Vogelaers D.

Int J Clin Pract. 2015 Nov;69(11):1257-67. doi: 10.1111/ijcp.12686. Epub 2015 Jul 6. Review.

6.

Mutual perception of communication between general practitioners and hospital-based specialists.

Vermeir P, Vandijck D, Degroote S, Ommeslag D, Van De Putte M, Heytens S, Reniers J, Hanoulle I, Peleman R, Vogelaers D.

Acta Clin Belg. 2015 Oct;70(5):350-6. doi: 10.1179/2295333715Y.0000000032. Epub 2015 Jun 4.

PMID:
26043268
7.

Influence of smart real-time electronic alerting on glucose control in critically ill patients.

Colpaert K, Oeyen S, Sijnave B, Peleman R, Benoit D, Decruyenaere J.

J Crit Care. 2015 Feb;30(1):216.e1-6. doi: 10.1016/j.jcrc.2014.07.030. Epub 2014 Aug 7.

PMID:
25194590
8.

Chronic diarrhea with hyperchloremic acidosis and hypokalemia.

Lepane C, Peleman R, Kinzie J.

Gastroenterology. 2012 Jan;142(1):e22-3. doi: 10.1053/j.gastro.2011.01.065. Epub 2011 Nov 19. No abstract available.

PMID:
22107713
9.

Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies.

Vandijck DM, Depuydt PO, Offner FC, Nollet J, Peleman RA, Steel E, Noens LA, Decruyenaere JM, Benoit DD.

Intensive Care Med. 2010 Oct;36(10):1744-50. doi: 10.1007/s00134-010-1903-8. Epub 2010 May 18.

PMID:
20480137
10.

Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital.

Buyle F, Vogelaers D, Peleman R, Van Maele G, Robays H.

Pharm World Sci. 2010 Jun;32(3):404-10. doi: 10.1007/s11096-010-9384-y. Epub 2010 Apr 1.

PMID:
20358404
11.

Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries.

Fusco FM, Puro V, Baka A, Bannister B, Brodt HR, Brouqui P, Follin P, Gjorup IE, Gottschalk R, Hemmer R, Hoepelman IM, Jarhall B, Kutsar K, Lanini S, Lyytikainen O, Maltezou HC, Mansinho K, Marti MC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamakii H, Skinhoj P, Trilla A, Vetter N, Ippolito G.

J Hosp Infect. 2009 Sep;73(1):15-23. doi: 10.1016/j.jhin.2009.06.009. Epub 2009 Jul 31.

PMID:
19647337
12.

Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease.

Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, Gottschalk R, Hemmer R, Maltezou HC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamäki H, Skinhoj P, Ippolito G; EUNID Working Group.

Lancet Infect Dis. 2009 May;9(5):301-11. doi: 10.1016/S1473-3099(09)70070-2.

PMID:
19393960
13.

Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patients.

Blot S, Cankurtaran M, Petrovic M, Vandijck D, Lizy C, Decruyenaere J, Danneels C, Vandewoude K, Piette A, Vershraegen G, Van Den Noortgate N, Peleman R, Vogelaers D.

Crit Care Med. 2009 May;37(5):1634-41. doi: 10.1097/CCM.0b013e31819da98e.

PMID:
19325489
14.

Predictive value of surveillance cultures and subsequent bacteremia with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Blot S, Depuydt P, Vandijck D, Vandewoude K, Peleman R, Vogelaers D.

Clin Infect Dis. 2008 Feb 1;46(3):481-2; author reply 482. doi: 10.1086/526349. No abstract available.

PMID:
18181753
15.

Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.

Vandijck DM, Depaemelaere M, Labeau SO, Depuydt PO, Annemans L, Buyle FM, Oeyen S, Colpaert KE, Peleman RP, Blot SI, Decruyenaere JM.

Int J Antimicrob Agents. 2008 Feb;31(2):161-5. doi: 10.1016/j.ijantimicag.2007.10.015.

PMID:
18164599
16.

Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.

Blot S, Vandijck D, Vandewoude K, Depuydt P, Vogelaers D, Peleman R.

J Antimicrob Chemother. 2007 Dec;60(6):1402. Epub 2007 Oct 3. No abstract available.

PMID:
17913718
17.
18.

Invasive devices: no need? No use!

Blot SI, Peleman R, Vandewoude KH.

Intensive Care Med. 2007 Feb;33(2):209-11. Epub 2006 Dec 5. No abstract available.

PMID:
17146631
19.

New and re-emerging infectious diseases: epidemics in waiting.

Peleman RA.

Curr Opin Anaesthesiol. 2004 Jun;17(3):265-70.

PMID:
17021562
20.

Mycobacterium avium complex with a distinct clinical and iconographic presentation: the Lady Windermere syndrome.

Goeminne H, Peleman RA, Brusselle G, Tournoy KG.

Acta Clin Belg. 2006 Mar-Apr;61(2):79-81.

PMID:
16792339
21.

Effect of fluconazole consumption on long-term trends in candidal ecology.

Blot S, Janssens R, Claeys G, Hoste E, Buyle F, De Waele JJ, Peleman R, Vogelaers D, Vandewoude K.

J Antimicrob Chemother. 2006 Aug;58(2):474-7. Epub 2006 Jun 6.

PMID:
16757503
22.

Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: a Belgian consensus report.

Peetermans WE, Van de Vyver N, Van Laethem Y, Van Damme P, Thiry N, Trefois P, Geerts P, Schetgen M, Peleman R, Swennen B, Verhaegen J.

Acta Clin Belg. 2005 Nov-Dec;60(6):329-37. Review.

PMID:
16502593
23.

Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.

Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):575-9.

PMID:
16018434
24.

Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist.

Bauters TG, Buyle FM, Peleman R, Robays H.

Pharm World Sci. 2005 Feb;27(1):31-4. Review.

PMID:
15861932
25.

Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.

Benoit DD, Depuydt PO, Peleman RA, Offner FC, Vandewoude KH, Vogelaers DP, Blot SI, Noens LA, Colardyn FA, Decruyenaere JM.

Intensive Care Med. 2005 Jul;31(7):934-42. Epub 2005 Mar 22.

PMID:
15782316
26.

Enzymatic differentiation of Candida parapsilosis from other Candida spp. in a membrane filtration test.

Bauters TG, Peleman R, Dhont M, Vanhaesebrouck P, Nelis HJ.

J Microbiol Methods. 2003 Apr;53(1):11-5.

PMID:
12609718
27.

Increased incidence of tuberculosis in immigrant dialysis populations.

Vanholder R, Peleman R.

Artif Organs. 2002 Aug;26(8):661-3. No abstract available.

PMID:
12139491
28.

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.

Kinzie JL, Naylor PH, Nathani MG, Peleman RR, Ehrinpreis MN, Lybik M, Turner JR, Janisse JJ, Massanari M, Mutchnick MG.

J Viral Hepat. 2001 Jul;8(4):264-9.

PMID:
11454177
29.

Isolations of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus.

de Baere T, Wauters G, Huylenbroeck A, Claeys G, Peleman R, Verschraegen G, Allemeersch D, Vaneechoutte M.

J Clin Microbiol. 2001 Apr;39(4):1674-5.

30.

Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy.

Siddiqui F, Mutchnick M, Kinzie J, Peleman R, Naylor P, Ehrinpreis M.

Am J Gastroenterol. 2001 Mar;96(3):858-63.

PMID:
11280565
31.

Isolation of Moraxella canis from an ulcerated metastatic lymph node.

Vaneechoutte M, Claeys G, Steyaert S, De Baere T, Peleman R, Verschraegen G.

J Clin Microbiol. 2000 Oct;38(10):3870-1.

32.

Mixed community-acquired fungal infection in an apparently healthy patient.

Benoit D, Peleman R, Claeys G, Hertveldt K, Vandewoude K.

Eur J Clin Microbiol Infect Dis. 2000 Aug;19(8):642-3. No abstract available.

PMID:
11014632
33.

Changing patterns of antibiotic resistance--update on antibiotic management of the infected vascular access.

Peleman RA, Vogelaers D, Verschraegen G.

Nephrol Dial Transplant. 2000 Sep;15(9):1281-4. Review. No abstract available.

PMID:
10978377
34.

The role of theophylline in asthma management.

Kips JC, Peleman RA, Pauwels RA.

Curr Opin Pulm Med. 1999 Mar;5(2):88-92. Review.

PMID:
10813257
35.

Indigenous malaria in a suburb of Ghent, Belgium.

Peleman R, Benoit D, Goossens L, Bouttens F, Puydt HD, Vogelaers D, Colardyn F, Van de Woude K.

J Travel Med. 2000 Jan;7(1):48-9.

36.

Prevention of pneumococcal disease: an update on the Belgian Consensus Report.

Peleman RA, Peetermans WE, Van Laethem Y, Bachez PG, Vanatoru J, Van Wassenhove K, Struelens MJ, Verhaegen JL.

Acta Clin Belg. 1999 Dec;54(6):321-7. Review.

PMID:
10686704
37.

Sensitization to inhaled antigen by intratracheal instillation of dendritic cells.

Lambrecht BN, Peleman RA, Bullock GR, Pauwels RA.

Clin Exp Allergy. 2000 Feb;30(2):214-24.

PMID:
10651774
38.

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.

Mutchnick MG, Lindsay KL, Schiff ER, Cummings GD, Appelman HD, Peleman RR, Silva M, Roach KC, Simmons F, Milstein S, Gordon SC, Ehrinpreis MN.

J Viral Hepat. 1999 Sep;6(5):397-403.

39.

Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia.

Peleman RA, Van De Velde V, Germonpré PR, Fleurinck C, Rosseel MT, Pauwels RA.

Antimicrob Agents Chemother. 2000 Jan;44(1):178-80.

40.

Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.

Steyaert S, Peleman R, Vaneechoutte M, De Baere T, Claeys G, Verschraegen G.

J Clin Microbiol. 1999 Nov;37(11):3778-9.

41.

The cellular composition of induced sputum in chronic obstructive pulmonary disease.

Peleman RA, Rytilä PH, Kips JC, Joos GF, Pauwels RA.

Eur Respir J. 1999 Apr;13(4):839-43.

42.

Membrane filtration test for rapid presumptive differentiation of four Candida species.

Bauters TG, Peleman R, Moerman M, Vermeersch H, de Looze D, Noens L, Nelis HJ.

J Clin Microbiol. 1999 May;37(5):1498-502.

43.

Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review.

Cuvelier I, Vogelaers D, Peleman R, Benoit D, Van Marck V, Offner F, Vandewoude K, Colardyn F.

Eur J Clin Microbiol Infect Dis. 1998 Dec;17(12):859-63. Review.

PMID:
10052550
44.

Therapeutic activities of theophylline in chronic obstructive pulmonary disease.

Peleman RA, Kips JC, Pauwels RA.

Clin Exp Allergy. 1998 Aug;28 Suppl 3:53-6. Review.

PMID:
9756187
45.

The need for a center-tailored treatment protocol for peritonitis.

Van Biesen W, Vanholder R, Vogelaers D, Peleman R, Verschraegen G, Vijt D, Lameire N.

Perit Dial Int. 1998 May-Jun;18(3):274-81.

PMID:
9663891
46.

Methods of examining induced sputum: do differences matter?

Kips JC, Peleman RA, Pauwels RA.

Eur Respir J. 1998 Mar;11(3):529-33. Review.

47.

Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12.

Bruselle GG, Kips JC, Peleman RA, Joos GF, Devos RR, Tavernier JH, Pauwels RA.

Am J Respir Cell Mol Biol. 1997 Dec;17(6):767-71.

PMID:
9409564
48.

Ultrasound and CT changes of liver parenchyma in acute schistosomiasis.

Cesmeli E, Vogelaers D, Voet D, Duyck P, Peleman R, Kunnen M, Afschrift M.

Br J Radiol. 1997 Jul;70(835):758-60.

PMID:
9245889
49.

Measurement of cefuroxime in human bronchoalveolar lavage fluid by high-performance liquid chromatography after solid-phase extraction.

Rosseel MT, Peleman R, Van Hoorebeke H, Pauwels RA.

J Chromatogr B Biomed Sci Appl. 1997 Feb 21;689(2):438-41.

PMID:
9080335
50.

Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.

Kips JC, Brusselle GJ, Joos GF, Peleman RA, Tavernier JH, Devos RR, Pauwels RA.

Am J Respir Crit Care Med. 1996 Feb;153(2):535-9.

PMID:
8564093

Supplemental Content

Loading ...
Support Center